Replacement of oral proton pump inhibitors with intravenous pantoprazole to effectively control gastric acid hypersecretion in patients with Zollinger-Ellison syndrome

American Journal of Gastroenterology

Volumn 96, Issue 12, 2001, Pages 3274-3280

  Metz, David C ^a   Forsmark, Christopher ^c   Lew, Edward A ^b   Starr, Julie A ^a   Soffer, Elaine F ^d   Bochenek, Wieslaw ^d   Pisegna, Joseph R ^b,e  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF FLORIDA   (United States)

^d WYETH AYERST RESEARCH   (United States)

^e VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTAMINE H2 RECEPTOR ANTAGONIST; LANSOPRAZOLE; OMEPRAZOLE; PANTOPRAZOLE; PROTON PUMP INHIBITOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; SIPPLE SYNDROME; STOMACH ACID SECRETION; STOMACH SURGERY; TACHYPHYLAXIS; UNITED STATES; ZOLLINGER ELLISON SYNDROME;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADMINISTRATION, ORAL; ADULT; AGED; BENZIMIDAZOLES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; FEMALE; GASTRIC ACID; HUMANS; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; OMEPRAZOLE; PROTON PUMPS; RETREATMENT; SULFOXIDES; ZOLLINGER-ELLISON SYNDROME;

EID: 0035666105     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(01)03887-4     Document Type: Article

References (21)

1. Zollinger-Ellison syndrome. Recent advances in the management of the gastrinoma
2. Zollinger-Ellison syndrome: Pathogenesis, diagnosis, and management
3. A prospective study of intraoperative methods to diagnose and resect duodenal gastrinomas
4. Assessment and prediction of long-term cure in patients with the Zollinger-Ellison syndrome: The best approach
5. Zollinger-Ellison syndrome: Diagnosis and management
6. Effects of curative gastrinoma resection on gastric secretory function and antisecretory drug requirement in the Zollinger-Ellison syndrome
7. Prospective study of the need for long-term antisecretory therapy in patients with Zollinger-Ellison syndrome following successful curative gastrinoma resection
8. Prospective study of the efficacy and safety of lansoprazole in Zollinger-Ellison syndrome
9. Zollinger-Ellison syndrome. Recognition and management of acid hypersecretion
10. Parenteral control of gastric acid hypersecretion in patients with Zollinger-Ellison syndrome
11. Pharmacokinetics of oral and intravenous omeprazole in patients with the Zollinger-Ellison syndrome et al.
12. Use of omeprazole in patients with Zollinger-Ellison syndrome
13. Stereologic investigations of human gastric mucosa. II. Oxyntic mucosa from patients with Zollinger-Ellison syndrome
14. (H+,K+)-ATPase inhibiting 2-[(2-pyridylmethyl)sulfinyl]benzimidazoles. 4. A novel series of dimethoxypyridyl-substituted inhibitors with enhanced selectivity. The selection of pantoprazole as a clinical candidate
15. Inhibition of pentagastrin-induced gastric acid secretion by intravenous pantoprazole: A dose response study
16. Intravenous pantoprazole is a novel proton pump inhibitor that rapidly and effectively controls gastric acid hypersecretion in patients with Zollinger-Ellison syndrome
17. Oral and intravenous dosage forms of pantoprazole are equivalent in their ability to suppress gastric acid secretion in patients with gastroesophageal reflux disease
18. Prospective study of the efficacy and safety of lansoprazole in Zollinger-Ellison syndrome
19. Assessment and prediction of long-term cure in patients with the Zollinger-Ellison syndrome: The best approach
20. Currently used doses of omeprazole in Zollinger-Ellison syndrome are too high
21. Effect of intravenous omeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers